BioSpace News Archive

Lone Star Bio

Castle Biosciences to Present at the 2018 Canaccord Genuity Medical Technologies & Diagnostics Forum

Castle Biosciences, Inc. today announced that Derek Maetzold will present at the Canaccord Genuity Medical Technologies & Diagnostics Forum.

November 8, 2018
·
1 min read
Business

MYOS RENS Technology Signs Distribution Agreement With Miller Veterinary Supply East To Bring Innovative MYOS Canine Muscle Formula™ To 6,000+ Veterinary Hospitals

First Distribution Agreement for MYOS Canine Muscle Formula™

November 8, 2018
·
4 min read
Business

Perrigo Company plc Reports Third Quarter 2018 Financial Results

Realized third quarter 2018 GAAP (“reported”) net sales of $1.1 billion, reported net loss of $68 million compared to a net income of $45 million last year and reported diluted loss per share of $0.49 compared to net earnings per share (“EPS”) of $0.31 last year

November 8, 2018
·
27 min read
Business

LabCorp and Horizon Blue Cross Blue Shield of New Jersey Renew Their Long-Standing Strategic Relationship

LabCorp will remain the exclusive in-network clinical laboratory for the nearly 900,000 Medicaid members of Horizon Blue Cross Blue Shield of New Jersey (Horizon BCBSNJ).

November 8, 2018
·
5 min read
Business

Endo Reports Third-Quarter 2018 Financial Results

Third-quarter 2018 revenues of $745 million compared to third-quarter 2017 revenues of $787 million

November 8, 2018
·
35 min read
Business

Cochlear and GN Hearing Strengthen Technology and Commercial Alliance to Develop Best-in-Class Integrated Hearing Solutions

Cochlear Limited and GN today signed a new agreement to significantly expand their Smart Hearing Alliance collaboration.

November 8, 2018
·
6 min read
Business

BioArctic Interim Report January - September 2018

BioArctic reports strong BAN2401 Phase 2b results for Alzheimer patients.

November 8, 2018
·
8 min read
Business

IRRAS AB (PUBL) Interim Report January-September 2018

Preparation for US launch of IRRAflow® ongoing, CE mark catheter re-certification now expected at YE 2018

November 8, 2018
·
4 min read
Job Trends

Marker Therapeutics to Present at Three Upcoming November 2018 Healthcare Conferences

Marker Therapeutics, Inc. today announced that its President and CEO, Peter L. Hoang, will participate in three upcoming healthcare conferences.

November 8, 2018
·
4 min read
Business

Sesen Bio Reports Third Quarter 2018 Financial Results and Planned VISTA Trial Readouts

Company Expects to Report Six-Month Update from VISTA Trial in December 2018; On-Track to Report 12-Month VISTA Trial Data in Mid-2019

November 8, 2018
·
7 min read